Life sciences news
-
Droia Ventures raises a new fund of EUR 220 million to target genetic diseases and expands leadership team with George Golumbeski
Tuesday May 11th 2021
Read more
-
Biocartis receives EUR 1.4m grant to support development of new Idylla™ technology to unlock potential in molecular surveillance
Tuesday May 11th 2021
Read more
-
Sequana Medical announces strong top-line results from RED DESERT alfapump DSR® study and expansion of DSR® development programme
Tuesday May 11th 2021
Read more
-
CD3 and VIB enter into an exclusive license and research collaboration with SpringWorks Therapeutics to develop TEAD inhibitors for addressing biomarker-defined cancers
Friday May 7th 2021
Read more
-
Biocartis announces new collaboration with AstraZeneca to expand availability of Idylla™ EGFR biomarker testing among patients with lung cancer
Wednesday May 5th 2021
Read more
-
miDiagnostics accelerates with launch of rapid COVID-19 PCR test product
Monday May 3rd 2021
Read more
-
New cancer immunotherapy treatment enters clinical phase
Thursday April 29th 2021
Read more
-
Precirix partners with Evergreen to expand North American clinical trial supply
Wednesday April 28th 2021
Read more
-
Become a flanders.bio member
Your news here?
-
Gilead Sciences submits new drug application in Japan for filgotinib for the treatment of ulcerative colitis with an inadequate response to conventional therapies
Friday April 23rd 2021
Read more
-
Biocartis and SkylineDx sign collaboration to develop the Merlin Assay
Thursday April 22nd 2021
Read more
-
Biotalys appoints Simon Moroney as Chairman of the Board
Wednesday April 21st 2021
Read more
More info?
Contact us
Ellen Telleir
Communication Coordinator
